Also trades as: PANACEABIO.BO (BSE) · $vol 0M
PANACEABIO.NS NSE
Panacea Biotec Limited
1W: -4.2%
1M: -8.2%
3M: -34.9%
YTD: -4.1%
1Y: -14.6%
3Y: +176.0%
5Y: +1.6%
₹353.00 ($3.67)
-6.05 (-1.69%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$12.6B
-2.1% ▼
5Y CAGR: +1.4%
Total Liabilities
$4.3B
-5.6% ▼
5Y CAGR: -21.0%
Shareholders Equity
$8.3B
+0.0% ▲
Cash & Investments
$744M
-58.5% ▼
5Y CAGR: -4.9%
Total Debt
$237M
+6.5% ▲
5Y CAGR: -50.8%
Net Debt
-$407M
+32.1% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $504M | $399M | $472M | $821M | $644M |
| Short-Term Investments | $5.0B | $1.7B | $1.1B | $889M | $100M |
| Cash & ST Investments | $5.5B | $2.1B | $1.6B | $1.8B | $744M |
| Net Receivables | $842M | $629M | $617M | $751M | $755M |
| Inventory | $2.1B | $2.0B | $1.8B | $2.1B | $1.9B |
| Other Current Assets | $1.4B | $851M | $832M | $773M | $1.7B |
| Total Current Assets | $9.9B | $5.7B | $4.9B | $5.5B | $5.1B |
| Property, Plant & Equip. | $6.3B | $6.2B | $6.3B | $6.4B | $6.5B |
| Goodwill & Intangibles | $138M | $259M | $360M | $423M | $509M |
| Long-Term Investments | -$4.2B | -$1.7B | $136M | $189M | $275M |
| Other Non-Current Assets | $142M | $1.4B | -$56M | $465M | $175M |
| Total Non-Current Assets | $7.7B | $7.0B | $7.6B | $7.4B | $7.5B |
| Total Assets | $17.6B | $12.7B | $12.4B | $12.9B | $12.6B |
| — Liabilities — | |||||
| Accounts Payable | $2.3B | $1.8B | $1.5B | $2.3B | $1.9B |
| Short-Term Debt | $520K | $550K | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $5.4B | $1.5B | $1.2B | $1.4B | $1.6B |
| Total Current Liabilities | $7.8B | $3.3B | $3.1B | $3.7B | $3.5B |
| Long-Term Debt | $341M | $202M | $210M | $222M | $237M |
| Other Non-Current Liab. | $316M | $265M | $282M | $358M | $378M |
| Total Non-Current Liabilities | $1.1B | $992M | $936M | $921M | $846M |
| Total Liabilities | $8.9B | $4.3B | $4.0B | $4.6B | $4.3B |
| — Equity — | |||||
| Common Stock | $61M | $61M | $61M | $61M | $61M |
| Retained Earnings | $8.2B | $7.9B | $7.9B | $7.8B | $0 |
| Accumulated OCI | -$461M | $0 | $0 | -$432M | $0 |
| Total Stockholders Equity | $8.8B | $8.4B | $8.4B | $8.3B | $8.3B |
| Total Liabilities & Equity | $17.6B | $12.7B | $12.4B | $12.9B | $12.6B |
| — Key Metrics — | |||||
| Total Debt | $342M | $202M | $210M | $222M | $237M |
| Net Debt | -$162M | -$196M | -$262M | -$599M | -$407M |
| Total Investments | $837M | $50M | $1.2B | $1.1B | $376M |